Davis Polk advised Lazard as financial adviser to Adamas Pharmaceuticals on the deal while Saul Ewing Arnstein & Lehr represented Supernus. Adamas Pharmaceuticals announced its $450 million...
Davis Polk advised Lazard as financial adviser to Adamas Pharmaceuticals on the deal while Saul Ewing Arnstein & Lehr represented Supernus. Adamas Pharmaceuticals announced its $450 million...
You must be a Standard 1 Year member to access this content.